These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6072896)

  • 1. Application of mutation of T2 phage from h+ to h to screening of antitumor antibiotics produced by actinomycetes.
    Nakamura S; Omura S; Hamada M; Nishimura T; Yamaki H
    J Antibiot (Tokyo); 1967 Jul; 20(4):217-22. PubMed ID: 6072896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitumor antibiotics produced by Actinomycetes].
    Gauze GF
    Mikrobiologiia; 1977; 46(5):821-7. PubMed ID: 600086
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibiotic substances inducing the formation of mature phage particles in a lysogenic culture of Micrococcus lysodeikticus and their production by Actinomycetes].
    Terekhova LP
    Antibiotiki; 1966 Oct; 11(10):901-6. PubMed ID: 5997594
    [No Abstract]   [Full Text] [Related]  

  • 4. A search for antitumor substances in the fermentation broths of actinomycetes active against antibiotic-resistant staphylococci.
    Ukleja-Bortkiewicz A; Tyc M; Abgarowicz G; Terlecka J
    Arch Immunol Ther Exp (Warsz); 1967; 15(5):760-4. PubMed ID: 5595077
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of the use of Staphylococcus aureus 209 mutant UV-2 at different stages of screening of new antineoplastic antibiotics].
    Kochetkova GV; Il'chenko GB; Kovsharova IN
    Antibiotiki; 1970 Jul; 15(7):587-90. PubMed ID: 4097990
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of actinomycetes antagonists of the Azureus section].
    Preobrazhenskaia TP
    Antibiotiki; 1966 Sep; 11(9):849-61. PubMed ID: 5996880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of the method of phage induction for the isolation and purification of antitumor antibiotics].
    Gauze GF; Terekhova LP; Kudinova MK; Rossolimo OK; Ukholina RS; Kovsharova IN; Nechaeva NP
    Antibiotiki; 1967 Mar; 12(3):179-83. PubMed ID: 4874765
    [No Abstract]   [Full Text] [Related]  

  • 8. [High molecular weight antineoplastic antibiotics of a polypeptide or protein nature formed by Actinomycetes].
    Kuimova TF
    Antibiotiki; 1966 Jul; 11(7):651-6. PubMed ID: 5997589
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antineoplastic antibiotic 4418 related to the antibiotics of the group pluramyciniomycin].
    Kudinova MK; Babenko GA; Ukholina RS; Maksimova TS; Nechaeva NP; Terekhova LP; Rossolimo OK
    Antibiotiki; 1968 Mar; 13(3):201-5. PubMed ID: 5672120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Distribution in the soil of actinophages, active against actinomyces--producers of novobiocin].
    Zhunaeva VV; Rautenshteĭn IaI
    Antibiotiki; 1967 Aug; 12(8):654-8. PubMed ID: 5588640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of different methods for the primary selection of antitumor antibiotics].
    Ivanitskaia LP; Upiter GD
    Antibiotiki; 1967 May; 12(5):369-74. PubMed ID: 5627678
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lienomycin production by strains of Actinomyces vendargensis Struyk et Stheeman, 1957].
    Shvesnikova MA; Maksimova TS; Ol'khovatova OL; Tuliakova TV; Lavrova MF
    Antibiotiki; 1973 Feb; 18(2):102-5. PubMed ID: 4776389
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiphage property as a screening test for antitumor agents.
    Aoki H; Sakai H
    J Antibiot (Tokyo); 1967 Mar; 20(2):87-92. PubMed ID: 6072428
    [No Abstract]   [Full Text] [Related]  

  • 14. [Production of antibiotic 1719 by Actinomyces cinereoviridis sp. nov].
    Korobkova TP; Terekhova LP; Maksimova TS; Kochetkova GV; Ol'khovatova OL
    Antibiotiki; 1972 Aug; 17(8):684-9. PubMed ID: 4564359
    [No Abstract]   [Full Text] [Related]  

  • 15. [New producer of carminomycin, Actinomycer cremeospinus sp. nov].
    Gauze GF; Terekhova LP; Maksimova TS; Ol'khovatova OL; Lavrova NV
    Antibiotiki; 1975 May; 20(5):389-93. PubMed ID: 1225185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Act. olivovariabilis sp.nov., an organism producing variamycin, a new antitumor antibiotic].
    Rudaia SM; Singal EM; Il'inskaia SA; Solov'eva NK
    Antibiotiki; 1971 Nov; 16(11):969-76. PubMed ID: 4947970
    [No Abstract]   [Full Text] [Related]  

  • 17. UCE6, a new antitumor antibiotic with topoisomerase I-mediated DNA cleavage activity produced by actinomycetes: producing organism, fermentation, isolation and biological activity.
    Fujii N; Tanaka F; Yamashita Y; Ashizawa T; Chiba S; Nakano H
    J Antibiot (Tokyo); 1997 Jun; 50(6):490-5. PubMed ID: 9268005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of aurantin on Act. species no. 2, which produces this antibiotic].
    Nefelova MV; Egorov NS
    Antibiotiki; 1971 Jun; 16(6):496-9. PubMed ID: 4106999
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microbiology and medical industry].
    Tuzhilkin IM
    Antibiotiki; 1970 Jul; 15(7):579-86. PubMed ID: 4920967
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of actinomycetes in the process of soil purification from pathogenic microorganisms].
    Kaliuzhna LD
    Mikrobiol Zh; 1971; 33(6):699-701. PubMed ID: 5153528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.